Opus Genetics (IRD) Stock: Buy, Sell, or Hold?
$4.06
-0.25 (-5.80%)
âŧ
5d:
+1.37%
30d:
-0.98%
90d:
+12.47%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (45%)
Quality Score
39/100
Position
FAIR
30-Day Fair Range
$3.69 â $4.38
Position: FAIR
Forward P/E & Valuation
-5.5x
Next 12M consensus est.
Wall Street Target
$13.59
+234.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.42 / $4.52
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: IRD is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When IRD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: IRD is currently trading at $4.06, which is considered fair relative to its 30-day fair value range of $3.69 to $4.38.
Technical Outlook: Technically, IRD is in a uptrend. Immediate support is located at $3.42, while resistance sits at $4.52. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: IRD scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.59 (+234.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IRD is in a uptrend. Immediate support is located at $3.42, while resistance sits at $4.52. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: IRD scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.59 (+234.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.69 -
$4.38
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
44.7%
Trading Range & Key Levels
30-Day Trading Range
$3.69 -
$4.38
Current vs Trading Range
FAIR
Support Level
$3.42
Resistance Level
$4.52
Current Trend
Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.8%)
- BULLISH: Trading 234.7% below Wall St target ($13.59)
- WARNING: Composite score 39/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-5.51
Wall Street Target
$13.59
(+234.7%)
Revenue Growth (YoY)
-63.1%
Share IRD Analysis
Share this live IRD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (IRD)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Wedbush and Chardan Capital raised their price targets for $IRD to $13 and $16, respectively.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 4:56 AM ET
Data refreshes hourly during market hours. Next update: 5:56 AM
Data refreshes hourly during market hours. Next update: 5:56 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IRD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
28 analysts |
$91 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 50 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 37 SELL |
|
RAPP
Rapport Therapeutics, InâĻ |
STRONG BUY
16 analysts |
$64 | 48 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive IRD Research Pages